Dipeptidylpeptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of Type 2 Diabetes

Brian Green, C.J. Bailey, P.R. Flatt

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)159-165
JournalDiabetes and Vascular Disease Research
Volume3
Issue number3
Publication statusPublished - 2006

Cite this